The government has broken its silence after a case of Super Gonorrhea infections was reported in the country.
In a Tuesday, January 17 TV interview, Dr. Patrick Amoth, the acting Director General at the Ministry of Health said the Super Gonorrhea infections report came from a study conducted on commercial sex workers.
Dr. Amoth said the report was conducted by the Kenya Medical Research Institute (KEMRI) on sex workers where out of 400 samples tested, one case was found to be resistant to nearly all antibiotics it was put through.
“This report came from a study that was conducted by KEMRI among commercial sex workers and out of the pathogens they looked at was Neisseria gonorrhoeae, the organism that causes gonorrhoea and out of that there were quite a number of pathogens that were resistant to ordinary antibiotics and in one particular individual, out of a sample of 400, was one that was resistant to nearly all the antibiotics we put it through,” Dr. Amoth said.
The Ministry of Health DG pointed out that the samples used in the study that confirmed the Super Gonorrhea case in Kenya was old data but noted that KEMRI was currently conducting a deeper review and analysis to establish the spread and span of the said strain of gonorrhea.
Dr. Amoth, however, underscored the importance of taking precautions noting that the gonorrhea strain reported to be resistant to all antimicrobials has also been reported in other countries including Japan, Thailand and the UK hence the rising risk of infection.
“KEMRI is doing a deep dive to be able to inform us further on the spread and span of this particular strain of gonorrhoea and once we have that information we will be able to put in place the appropriate interventions to forestall it. This was from slightly old data but is very pertinent. This has also been reported in other jurisdictions such as Japan, Thailand and the UK. So we are not an isolated community so we need to take it seriously,” said Dr. Amoth.
Also Read: National Assembly Health Committee to Tour KEMSA
He urged Kenyans to take the necessary protective measures such as use of condoms and reducing the number of sexual partners.
According to the World Health Organization (WHO) Super gonorrhoea, also referred to as super-resistant gonorrhoea, is an extensively drug-resistant gonorrhoea with high-level resistance to the current recommended treatment for gonorrhoea (ceftriaxone and azithromycin) including resistance to penicillin, sulphonamides, tetracycline, fluoroquinolones, macrolides.
A spokesman from the World Health Organization (WHO) was quoted stating that the overuse of azithromycin for COVID-19 was directly leading to drug-resistant strains of Gonorrhea.
Dr. Teodora Wi, a World Health Organisation Medical Officer, specializing in STIs, the rise of resistant gonorrhoea is being caused by factors including unrestricted access to antimicrobials, inappropriate selection and overuse of antibiotics and suboptimal quality of antibiotics.
Other reasons are; inherent genetic mutations within the organism which have contributed to the development of a pattern of resistance in Neisseria gonorrhoeae and extra genital infections – anorectal and pharyngeal – particularly affecting key populations such as men who have sex with men
